Cargando…

An ethics safe harbor for international genomics research?

BACKGROUND: Genomics research is becoming increasingly globally connected and collaborative, contesting traditional ethical and legal boundaries between global and local research practice. As well, global data-driven genomics research holds great promise for health discoveries. Yet, paradoxically, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dove, Edward S, Knoppers, Bartha M, Zawati, Ma’n H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978721/
https://www.ncbi.nlm.nih.gov/pubmed/24267880
http://dx.doi.org/10.1186/gm503
_version_ 1782310621571710976
author Dove, Edward S
Knoppers, Bartha M
Zawati, Ma’n H
author_facet Dove, Edward S
Knoppers, Bartha M
Zawati, Ma’n H
author_sort Dove, Edward S
collection PubMed
description BACKGROUND: Genomics research is becoming increasingly globally connected and collaborative, contesting traditional ethical and legal boundaries between global and local research practice. As well, global data-driven genomics research holds great promise for health discoveries. Yet, paradoxically, current research ethics review systems around the world challenge potential improvements in human health from such research and thus undermine respect for research participants. Case reports illustrate that the current system is costly, fragmented, inefficient, inadequate, and inconsistent. There is an urgent need to improve the governance system of ethics review to enable secure and seamless genomic and clinical data sharing across jurisdictions. DISCUSSION: Building on the international privacy 'safe harbor’ model that was developed following the adoption of the European Privacy Directive, we propose an international infrastructure. The goal is to create a streamlined and harmonized ethics governance system for international, data-driven genomics research projects. The proposed 'Safe Harbor Framework for International Ethics Equivalency’ would consist in part of an agency supporting an International Federation for Ethics Review (IFER), formed by a voluntary agreement among countries, granting agencies, philanthropies, institutions, and healthcare, patient advocacy, and research organizations. IFER would be both a central ethics review body and also a forum for review and follow-up of policies concerning ethics norms for international genomics research projects. It would be built on five principle elements: (1) registration; (2) compliance review; (3) recognition; (4) monitoring and enforcement; and (5) public participation. SUMMARY: A Safe Harbor Framework for International Ethics Equivalency would create many benefits for researchers, countries, and the general public, and may eventually have application beyond genomics to other areas of biomedical research that increasingly engage in secondary use of data and present only negligible risks. Among the benefits, research participants and patients would have uniform adequate protection, while researchers would be ensured expert ethics review with a reduction in cost, time, administrative hassle, and redundant regulatory hurdles. Most importantly, society would enjoy the maximization of the potential benefits of genomics research.
format Online
Article
Text
id pubmed-3978721
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39787212014-04-12 An ethics safe harbor for international genomics research? Dove, Edward S Knoppers, Bartha M Zawati, Ma’n H Genome Med Open Debate BACKGROUND: Genomics research is becoming increasingly globally connected and collaborative, contesting traditional ethical and legal boundaries between global and local research practice. As well, global data-driven genomics research holds great promise for health discoveries. Yet, paradoxically, current research ethics review systems around the world challenge potential improvements in human health from such research and thus undermine respect for research participants. Case reports illustrate that the current system is costly, fragmented, inefficient, inadequate, and inconsistent. There is an urgent need to improve the governance system of ethics review to enable secure and seamless genomic and clinical data sharing across jurisdictions. DISCUSSION: Building on the international privacy 'safe harbor’ model that was developed following the adoption of the European Privacy Directive, we propose an international infrastructure. The goal is to create a streamlined and harmonized ethics governance system for international, data-driven genomics research projects. The proposed 'Safe Harbor Framework for International Ethics Equivalency’ would consist in part of an agency supporting an International Federation for Ethics Review (IFER), formed by a voluntary agreement among countries, granting agencies, philanthropies, institutions, and healthcare, patient advocacy, and research organizations. IFER would be both a central ethics review body and also a forum for review and follow-up of policies concerning ethics norms for international genomics research projects. It would be built on five principle elements: (1) registration; (2) compliance review; (3) recognition; (4) monitoring and enforcement; and (5) public participation. SUMMARY: A Safe Harbor Framework for International Ethics Equivalency would create many benefits for researchers, countries, and the general public, and may eventually have application beyond genomics to other areas of biomedical research that increasingly engage in secondary use of data and present only negligible risks. Among the benefits, research participants and patients would have uniform adequate protection, while researchers would be ensured expert ethics review with a reduction in cost, time, administrative hassle, and redundant regulatory hurdles. Most importantly, society would enjoy the maximization of the potential benefits of genomics research. BioMed Central 2013-11-22 /pmc/articles/PMC3978721/ /pubmed/24267880 http://dx.doi.org/10.1186/gm503 Text en Copyright © 2013 Dove et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Open Debate
Dove, Edward S
Knoppers, Bartha M
Zawati, Ma’n H
An ethics safe harbor for international genomics research?
title An ethics safe harbor for international genomics research?
title_full An ethics safe harbor for international genomics research?
title_fullStr An ethics safe harbor for international genomics research?
title_full_unstemmed An ethics safe harbor for international genomics research?
title_short An ethics safe harbor for international genomics research?
title_sort ethics safe harbor for international genomics research?
topic Open Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978721/
https://www.ncbi.nlm.nih.gov/pubmed/24267880
http://dx.doi.org/10.1186/gm503
work_keys_str_mv AT doveedwards anethicssafeharborforinternationalgenomicsresearch
AT knoppersbartham anethicssafeharborforinternationalgenomicsresearch
AT zawatimanh anethicssafeharborforinternationalgenomicsresearch
AT doveedwards ethicssafeharborforinternationalgenomicsresearch
AT knoppersbartham ethicssafeharborforinternationalgenomicsresearch
AT zawatimanh ethicssafeharborforinternationalgenomicsresearch